<- Go Home
Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of proprietary life support technology for the treatment of acute respiratory failure. Its lead product is the INSPIRA augmented respiration technology (Gen 2) device, a life support designed to provide Adaptive Blood Oxygenation that to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.
Market Cap
$25.2M
Volume
203.4K
Cash and Equivalents
$5.0M
EBITDA
-$12.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$2.49
52 Week Low
$0.76
Dividend
N/A
Price / Book Value
3.71
Price / Earnings
-1.46
Price / Tangible Book Value
3.71
Enterprise Value
$18.7M
Enterprise Value / EBITDA
-1.55
Operating Income
-$12.1M
Return on Equity
116.54%
Return on Assets
-59.53
Cash and Short Term Investments
$7.4M
Debt
$878.0K
Equity
$5.7M
Revenue
N/A
Unlevered FCF
-$4.7M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium